Alpine Immune Sciences Inc. (ALPN) NASDAQ

$7.95 -0.05 (-0.62%)

Market Cap: $241.11M

As of 05/18/22 04:00 PM EDT. Market closed.

(ALPN)

Alpine Immune Sciences Inc. (ALPN) NASDAQ

$7.95 -0.05 (-0.62%)

Market Cap: $241.11M

As of 05/18/22 04:00 PM EDT. Market closed.

Alpine Immune Sciences, Inc. is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients' lives. Alpine has entered into ... read more

Alpine Immune Sciences, Inc. is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients' lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Charles Scoggin
Full Time Employees
57
URL
Address
188 East Blaine St., Suite 200, Washington, Seattle, 98102.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Charles Scoggin
Full Time Employees
57
Address
188 East Blaine St., Suite 200, Washington, Seattle, 98102.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$8.04
Previous Close
$8
Days Range
$7.66 - $8.09
52 week range
$6 - $15.14
Volume
79,215
Avg. Volume (30 days)
89,067
Market Cap
$241.11M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
30,328,462
Open
$8.04
Previous Close
$8
Days Range
$7.66 - $8.09
52 week range
$6 - $15.14
Volume
79,215
Avg. Volume (30 days)
89,067
Market Cap
$241.11M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
30,328,462

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ALPINE IMMUNE SCIENCES INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Frazier Life Sciences VIII, L.P. 10% Owner Feb 11, 2022 Buy $7.10 112,665 799,989 1,484,115 Feb 15, 2022, 05:00 PM
Peetz Christopher Director Sep 23, 2021 Buy $10.17 1,900 19,323 1,900 Sep 27, 2021, 07:03 AM
CONWAY ROBERT E Director Sep 23, 2021 Buy $10.08 15,000 151,153 50,000 Sep 27, 2021, 07:02 AM
CONWAY ROBERT E Director Sep 23, 2021 Sale $10.08 15,000 151,153 50,000 Sep 24, 2021, 06:39 PM
Peetz Christopher Director Sep 23, 2021 Sale $10.17 1,900 19,323 1,900 Sep 24, 2021, 05:32 PM
CONWAY ROBERT E Director Sep 21, 2021 Buy $9.80 10,000 97,966 35,000 Sep 23, 2021, 08:31 PM
ORBIMED ADVISORS LLC Director Sep 17, 2021 Buy $9.40 1,010,637 9,499,987 3,656,061 Sep 21, 2021, 06:42 PM
Decheng Capital China Life Sciences USD Fund III, L.P. 10% Owner Sep 17, 2021 Buy $9.40 1,542,553 14,499,998 4,708,288 Sep 21, 2021, 06:39 PM
Thompson Peter A. Director Sep 17, 2021 Buy $9.40 1,010,637 9,499,987 3,656,061 Sep 21, 2021, 06:38 PM
Alpine ImmunoSciences, L.P. 10% Owner Sep 17, 2021 Sale $9.40 400,000 3,760,000 2,600,980 Sep 21, 2021, 05:18 PM
GOLD MITCHELL Executive Chairman and CEO Sep 17, 2021 Sale $9.40 400,000 3,760,000 2,600,980 Sep 21, 2021, 05:16 PM
GOLD MITCHELL Executive Chairman and CEO Sep 17, 2021 Sale $10.01 45,262 452,964 109,387 Sep 21, 2021, 05:16 PM
Venkatesan Jay Director Sep 17, 2021 Sale $9.40 400,000 3,760,000 2,600,980 Sep 21, 2021, 05:14 PM
Cui Xiangmin Director Sep 17, 2021 Buy $9.40 1,542,553 14,499,998 4,708,288 Sep 21, 2021, 05:12 PM
GOLD MITCHELL Executive Chairman and CEO Sep 16, 2021 Sale $10.00 6,768 67,696 154,649 Sep 17, 2021, 06:06 PM
GOLD MITCHELL Executive Chairman and CEO Sep 15, 2021 Sale $10.00 3,484 34,840 161,417 Sep 17, 2021, 06:06 PM
GOLD MITCHELL Executive Chairman and CEO Jun 28, 2021 Sale $10.00 3,479 34,792 164,901 Jun 29, 2021, 05:13 PM
GOLD MITCHELL Executive Chairman and CEO Jun 25, 2021 Sale $10.01 9,473 94,865 168,380 Jun 29, 2021, 05:13 PM
GOLD MITCHELL Executive Chairman and CEO May 20, 2021 Sale $15.00 1,221 18,316 177,853 May 21, 2021, 05:16 PM
GOLD MITCHELL Executive Chairman and CEO May 19, 2021 Sale $15.03 50,965 765,917 179,074 May 21, 2021, 05:16 PM
Venkatesan Jay Director Mar 30, 2021 Option Exercise $4.09 7,650 31,289 210,413 Apr 23, 2021, 06:14 PM
Venkatesan Jay Director Mar 31, 2021 Option Exercise $3.62 7,650 27,718 218,063 Apr 23, 2021, 06:14 PM
GOLD MITCHELL Executive Chairman and CEO Apr 14, 2021 Sale $10.52 10,000 105,200 250,039 Apr 15, 2021, 06:09 PM
GOLD MITCHELL Executive Chairman and CEO Apr 13, 2021 Sale $10.07 10,000 100,714 260,039 Apr 15, 2021, 06:09 PM
GOLD MITCHELL Executive Chairman and CEO Mar 05, 2021 Sale $12.99 10,000 129,875 270,039 Mar 08, 2021, 05:01 PM
GOLD MITCHELL Executive Chairman and CEO Mar 04, 2021 Sale $13.01 10,000 130,108 280,039 Mar 08, 2021, 05:01 PM
GOLD MITCHELL Executive Chairman and CEO Feb 01, 2021 Sale $12.87 10,000 128,665 307,060 Feb 03, 2021, 05:01 PM
GOLD MITCHELL Executive Chairman and CEO Feb 02, 2021 Sale $11.74 10,000 117,381 290,039 Feb 03, 2021, 05:01 PM
PENG STANFORD L See Remarks Dec 31, 2020 Option Exercise $12.60 3,923 49,430 24,371 Jan 04, 2021, 08:41 PM
GOLD MITCHELL Executive Chairman and CEO Dec 31, 2020 Option Exercise $12.60 11,123 140,150 310,039 Jan 04, 2021, 08:37 PM
Rickey James Paul Senior VP and CFO Dec 31, 2020 Option Exercise $12.60 2,258 28,451 24,027 Jan 04, 2021, 08:31 PM
ORBIMED ADVISORS LLC Director Dec 28, 2020 Sale $14.25 600,000 8,550,000 3,070,955 Dec 30, 2020, 04:44 PM
Thompson Peter A. Director Dec 28, 2020 Sale $14.25 600,000 8,550,000 3,070,955 Dec 30, 2020, 04:38 PM
CONWAY ROBERT E Director Nov 19, 2020 Buy $8.03 10,000 80,300 25,000 Nov 23, 2020, 05:00 PM
Rickey James Paul Senior VP and CFO Jun 30, 2020 Option Exercise $9.71 2,258 21,925 26,285 Jul 01, 2020, 07:38 PM
GOLD MITCHELL Executive Chairman and CEO Jun 30, 2020 Option Exercise $9.71 8,227 79,884 60,634 Jul 01, 2020, 07:24 PM
PENG STANFORD L See Remarks Jun 30, 2020 Option Exercise $9.71 3,923 38,092 28,294 Jul 01, 2020, 07:24 PM
Rickey James Paul Senior VP and CFO May 30, 2019 Buy $4.95 10,000 49,500 10,000 Jun 03, 2019, 08:00 AM
TIGER MANAGEMENT L.L.C. 10% Owner Feb 08, 2019 Sale $5.85 25,000 146,245 137,728 Feb 12, 2019, 01:52 PM
Cui Xiangmin Director Jan 18, 2019 Option Exercise $5.37 3,165,735 16,999,997 3,165,735 Jan 23, 2019, 08:48 PM
Thompson Peter A. Director Jan 18, 2019 Buy $5.37 372,439 1,999,997 3,670,955 Jan 23, 2019, 06:01 PM
ORBIMED ADVISORS LLC Director Jan 18, 2019 Buy $5.37 372,439 1,999,997 3,670,955 Jan 23, 2019, 05:58 PM
Alpine ImmunoSciences, L.P. 10% Owner Jan 18, 2019 Buy $5.37 190,875 1,024,999 3,994,781 Jan 22, 2019, 08:46 PM
GOLD MITCHELL Executive Chairman and CEO Jan 18, 2019 Buy $5.37 190,875 1,024,999 3,994,781 Jan 22, 2019, 08:44 PM
Venkatesan Jay Director Jan 18, 2019 Buy $5.37 190,875 1,024,999 3,994,781 Jan 22, 2019, 08:44 PM
Frazier Life Sciences VIII, L.P. 10% Owner Jan 18, 2019 Buy $5.37 372,439 1,999,997 2,571,450 Jan 22, 2019, 05:14 PM
Topper James N Director Jan 18, 2019 Buy $5.37 372,439 1,999,997 2,571,450 Jan 22, 2019, 05:09 PM
BVF PARTNERS L P/IL 10% Owner Jun 20, 2017 Buy $2.25 17,806 40,064 1,109,258 Jun 22, 2017, 05:08 PM
BVF PARTNERS L P/IL 10% Owner Jun 07, 2017 Buy $2.28 36,900 84,180 1,099,526 Jun 07, 2017, 06:21 PM
BVF PARTNERS L P/IL 10% Owner Jun 05, 2017 Buy $2.29 35,750 81,889 1,079,345 Jun 07, 2017, 06:21 PM
BVF PARTNERS L P/IL 10% Owner May 31, 2017 Buy $2.25 28,100 63,141 1,060,139 Jun 01, 2017, 05:11 PM
BVF PARTNERS L P/IL 10% Owner May 30, 2017 Buy $2.30 18,900 43,389 1,044,789 Jun 01, 2017, 05:11 PM
BVF PARTNERS L P/IL 10% Owner May 18, 2017 Buy $2.30 29,886 68,732 1,028,344 May 19, 2017, 06:21 PM
BVF PARTNERS L P/IL 10% Owner May 17, 2017 Buy $2.30 37,372 85,907 1,011,908 May 19, 2017, 06:21 PM
BVF PARTNERS L P/IL 10% Owner May 19, 2017 Buy $2.30 11,600 26,680 1,034,597 May 19, 2017, 06:21 PM
BVF PARTNERS L P/IL 10% Owner May 11, 2017 Buy $2.34 7,034 16,480 986,943 May 11, 2017, 06:52 PM
BVF PARTNERS L P/IL 10% Owner May 10, 2017 Buy $2.35 62,000 145,433 983,149 May 11, 2017, 06:52 PM
BVF PARTNERS L P/IL 10% Owner May 09, 2017 Buy $2.29 40,000 91,516 949,458 May 11, 2017, 06:52 PM
CONWAY ROBERT E Director May 08, 2017 Buy $2.28 15,000 34,200 60,000 May 11, 2017, 12:17 PM
CONWAY ROBERT E Director May 09, 2017 Buy $2.34 5,000 11,700 45,000 May 10, 2017, 02:00 PM
TROHA JANICE Exec Vice President / COO May 05, 2017 Buy $2.34 10,000 23,400 10,000 May 09, 2017, 02:01 PM
CONWAY ROBERT E Director May 05, 2017 Buy $2.30 20,000 46,000 40,000 May 09, 2017, 02:01 PM
CONWAY ROBERT E Director May 04, 2017 Buy $2.26 10,000 22,600 20,000 May 08, 2017, 02:00 PM
Rodman David Malcom Exec Vice President and CMO Jan 04, 2017 Sale $2.27 6,687 15,179 11,368 Jan 05, 2017, 11:00 AM
Carruthers R Michael Exec Vice President / CFO Dec 02, 2016 Buy $2.09 24,000 50,256 24,000 Dec 05, 2016, 04:26 PM
Rodman David Malcom Exec Vice President and CMO Oct 04, 2016 Sale $7.96 5,820 46,327 12,236 Oct 05, 2016, 04:16 PM
Rodman David Malcom Exec Vice President and CMO Jul 05, 2016 Sale $4.66 5,950 27,727 12,105 Jul 06, 2016, 04:15 PM
Congleton Jon President and CEO Jun 16, 2016 Buy $3.87 5,000 19,345 20,000 Jun 17, 2016, 10:51 AM
Congleton Jon President and CEO Mar 24, 2016 Buy $4.22 5,000 21,084 15,000 Mar 25, 2016, 11:21 AM
Congleton Jon President and CEO Mar 22, 2016 Buy $4.38 5,000 21,907 10,000 Mar 23, 2016, 04:31 PM
Congleton Jon President and CEO Dec 11, 2015 Buy $8.10 5,000 40,500 5,000 Dec 14, 2015, 12:50 PM
CONWAY ROBERT E Director Dec 09, 2015 Buy $8.10 10,000 81,000 10,000 Dec 11, 2015, 09:01 AM
Flynn James E 10% Owner Jun 23, 2015 Buy $14.00 104,795 1,467,130 1,124,740 Jun 25, 2015, 03:14 PM
Flynn James E 10% Owner Jun 23, 2015 Buy $14.00 77,539 1,085,546 832,216 Jun 25, 2015, 03:14 PM
Flynn James E 10% Owner Jun 23, 2015 Buy $14.00 67,666 947,324 726,242 Jun 25, 2015, 03:14 PM
Rock Springs Capital Management LP 10% Owner Jun 22, 2015 Buy $14.00 200,000 2,800,000 564,358 Jun 24, 2015, 04:09 PM
Hawkes Bay Master Investors (Cayman) L.P. 10% Owner Jun 22, 2015 Buy $14.75 5,500 81,113 37,600 Jun 23, 2015, 02:11 PM
Hawkes Bay Master Investors (Cayman) L.P. 10% Owner Jun 19, 2015 Buy $14.67 11,700 171,591 32,100 Jun 23, 2015, 02:11 PM
Jennison Global Healthcare Master Fund, Ltd. 10% Owner Jun 22, 2015 Option Exercise $14.00 303,631 4,250,834 329,780 Jun 22, 2015, 06:26 PM
Jennison Global Healthcare Master Fund, Ltd. 10% Owner Jun 17, 2015 Buy $14.00 26,149 366,086 26,149 Jun 19, 2015, 04:55 PM
Hawkes Bay Master Investors (Cayman) L.P. 10% Owner Jun 18, 2015 Buy $14.75 6,200 91,450 20,400 Jun 19, 2015, 01:13 PM
Hawkes Bay Master Investors (Cayman) L.P. 10% Owner Jun 17, 2015 Buy $14.35 14,200 203,825 14,200 Jun 19, 2015, 01:13 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Frazier Life Sciences VIII, L.P. 10% Owner 02/11/2022 799,989
Peetz Christopher Director 09/23/2021 19,323
CONWAY ROBERT E Director 09/23/2021 151,153
CONWAY ROBERT E Director 09/23/2021 151,153
Peetz Christopher Director 09/23/2021 19,323
CONWAY ROBERT E Director 09/21/2021 97,966
ORBIMED ADVISORS LLC Director 09/17/2021 9,499,987
Decheng Capital China Life Sciences USD Fund III, L.P. 10% Owner 09/17/2021 14,499,998
Thompson Peter A. Director 09/17/2021 9,499,987
Alpine ImmunoSciences, L.P. 10% Owner 09/17/2021 3,760,000
GOLD MITCHELL Executive Chairman and CEO 09/17/2021 3,760,000
GOLD MITCHELL Executive Chairman and CEO 09/17/2021 452,964
Venkatesan Jay Director 09/17/2021 3,760,000
Cui Xiangmin Director 09/17/2021 14,499,998
GOLD MITCHELL Executive Chairman and CEO 09/16/2021 67,696
GOLD MITCHELL Executive Chairman and CEO 09/15/2021 34,840
GOLD MITCHELL Executive Chairman and CEO 06/28/2021 34,792
GOLD MITCHELL Executive Chairman and CEO 06/25/2021 94,865
GOLD MITCHELL Executive Chairman and CEO 05/20/2021 18,316
GOLD MITCHELL Executive Chairman and CEO 05/19/2021 765,917
Venkatesan Jay Director 03/30/2021 31,289
Venkatesan Jay Director 03/31/2021 27,718
GOLD MITCHELL Executive Chairman and CEO 04/14/2021 105,200
GOLD MITCHELL Executive Chairman and CEO 04/13/2021 100,714
GOLD MITCHELL Executive Chairman and CEO 03/05/2021 129,875
GOLD MITCHELL Executive Chairman and CEO 03/04/2021 130,108
GOLD MITCHELL Executive Chairman and CEO 02/01/2021 128,665
GOLD MITCHELL Executive Chairman and CEO 02/02/2021 117,381
PENG STANFORD L See Remarks 12/31/2020 49,430
GOLD MITCHELL Executive Chairman and CEO 12/31/2020 140,150
Rickey James Paul Senior VP and CFO 12/31/2020 28,451
ORBIMED ADVISORS LLC Director 12/28/2020 8,550,000
Thompson Peter A. Director 12/28/2020 8,550,000
CONWAY ROBERT E Director 11/19/2020 80,300
Rickey James Paul Senior VP and CFO 06/30/2020 21,925
GOLD MITCHELL Executive Chairman and CEO 06/30/2020 79,884
PENG STANFORD L See Remarks 06/30/2020 38,092
Rickey James Paul Senior VP and CFO 05/30/2019 49,500
TIGER MANAGEMENT L.L.C. 10% Owner 02/08/2019 146,245
Cui Xiangmin Director 01/18/2019 16,999,997
Thompson Peter A. Director 01/18/2019 1,999,997
ORBIMED ADVISORS LLC Director 01/18/2019 1,999,997
Alpine ImmunoSciences, L.P. 10% Owner 01/18/2019 1,024,999
GOLD MITCHELL Executive Chairman and CEO 01/18/2019 1,024,999
Venkatesan Jay Director 01/18/2019 1,024,999
Frazier Life Sciences VIII, L.P. 10% Owner 01/18/2019 1,999,997
Topper James N Director 01/18/2019 1,999,997
BVF PARTNERS L P/IL 10% Owner 06/20/2017 40,064
BVF PARTNERS L P/IL 10% Owner 06/07/2017 84,180
BVF PARTNERS L P/IL 10% Owner 06/05/2017 81,889
BVF PARTNERS L P/IL 10% Owner 05/31/2017 63,141
BVF PARTNERS L P/IL 10% Owner 05/30/2017 43,389
BVF PARTNERS L P/IL 10% Owner 05/18/2017 68,732
BVF PARTNERS L P/IL 10% Owner 05/17/2017 85,907
BVF PARTNERS L P/IL 10% Owner 05/19/2017 26,680
BVF PARTNERS L P/IL 10% Owner 05/11/2017 16,480
BVF PARTNERS L P/IL 10% Owner 05/10/2017 145,433
BVF PARTNERS L P/IL 10% Owner 05/09/2017 91,516
CONWAY ROBERT E Director 05/08/2017 34,200
CONWAY ROBERT E Director 05/09/2017 11,700
TROHA JANICE Exec Vice President / COO 05/05/2017 23,400
CONWAY ROBERT E Director 05/05/2017 46,000
CONWAY ROBERT E Director 05/04/2017 22,600
Rodman David Malcom Exec Vice President and CMO 01/04/2017 15,179
Carruthers R Michael Exec Vice President / CFO 12/02/2016 50,256
Rodman David Malcom Exec Vice President and CMO 10/04/2016 46,327
Rodman David Malcom Exec Vice President and CMO 07/05/2016 27,727
Congleton Jon President and CEO 06/16/2016 19,345
Congleton Jon President and CEO 03/24/2016 21,084
Congleton Jon President and CEO 03/22/2016 21,907
Congleton Jon President and CEO 12/11/2015 40,500
CONWAY ROBERT E Director 12/09/2015 81,000
Flynn James E 10% Owner 06/23/2015 1,467,130
Flynn James E 10% Owner 06/23/2015 1,085,546
Flynn James E 10% Owner 06/23/2015 947,324
Rock Springs Capital Management LP 10% Owner 06/22/2015 2,800,000
Hawkes Bay Master Investors (Cayman) L.P. 10% Owner 06/22/2015 81,113
Hawkes Bay Master Investors (Cayman) L.P. 10% Owner 06/19/2015 171,591
Jennison Global Healthcare Master Fund, Ltd. 10% Owner 06/22/2015 4,250,834
Jennison Global Healthcare Master Fund, Ltd. 10% Owner 06/17/2015 366,086
Hawkes Bay Master Investors (Cayman) L.P. 10% Owner 06/18/2015 91,450
Hawkes Bay Master Investors (Cayman) L.P. 10% Owner 06/17/2015 203,825
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2018
03/31/2018
0.02%
1Q
06/30/2018
06/30/2017
-11.52%
4Q
06/30/2018
03/31/2017
-11.49%
5Q
06/30/2018
12/31/2016
-10.62%
6Q
06/30/2018
09/30/2016
-10.53%
7Q
06/30/2018
06/30/2016
-10.45%
8Q
06/30/2018
03/31/2016
-10.45%
9Q
Load More

Period of Report: 06/30/2018

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2018
0.02%
1Q
06/30/2017
-11.52%
4Q
03/31/2017
-11.49%
5Q
12/31/2016
-10.62%
6Q
09/30/2016
-10.53%
7Q
06/30/2016
-10.45%
8Q
03/31/2016
-10.45%
9Q
Load More